TrialThe Journal of infectious diseases2022

Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.

Zoe Moodie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.